Hosokawa, Kohei https://orcid.org/0000-0002-3423-1523
Funding for this research was provided by:
Kanazawa University
Article History
Received: 23 December 2025
Revised: 26 May 2026
Accepted: 28 May 2026
First Online: 8 June 2026
Declarations
:
: Kohei Hosokawa has received honoraria for lectures from Alexion Pharmaceuticals, Inc., Chugai Pharmaceutical Co., Ltd., Novartis Pharma K.K., Kyowa Kirin Co., Ltd., and Bristol-Myers Squibb K.K.. He serves as an unpaid board member of the International PNH Interest Group (IPIG).